In this paper we discuss the value of N-of-1 trials in personalising health care. We describe the challenges faced in implementing N-of-1 trials in the United Kingdom's National Health Service and suggest how making greater use of these personalised trials might be facilitated
_logo.svg%3Fwidth%3D300&w=3840&q=75){kind=logo}
Although cannabis-based products for medicinal use are now legal in the UK, it is still challenging ...
AbstractObjectivesTo explore the economic viability of N-of-1 trials for improving access to selecte...
BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study c...
Abstract Background Double-blind randomised N-of-1 trials (N-of-1 trials) may help with decisions co...
Context:When feasible, randomized, blinded single-patient (n-of-1) trials are uniquely capable of es...
Precision medicine typically refers to the use of genomic signatures of patients to assign more effe...
This is the final version of the article. Available from BioMed Central via the DOI in this record.B...
Clinicians and patients often try a treatment for an initial period to inform longer-term therapeuti...
Background: N-of-1 trials offer an innovative approach to delivering personalized clinical care toge...
AbstractN-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a ...
BACKGROUND: Many people now take multiple medications on a long-term basis to manage health conditio...
Treatment of patients who suffer from concurrent health conditions is not well served by (1) evidenc...
Objective: To explore the economic viability of N-of-1 trials for improving access to selected high ...
The aim of this article is to provide readers who have not yet undertaken n-of-1 or within-subject e...
BackgroundMany people now take multiple medications on a long-term basis to manage health conditions...
Although cannabis-based products for medicinal use are now legal in the UK, it is still challenging ...
AbstractObjectivesTo explore the economic viability of N-of-1 trials for improving access to selecte...
BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study c...
Abstract Background Double-blind randomised N-of-1 trials (N-of-1 trials) may help with decisions co...
Context:When feasible, randomized, blinded single-patient (n-of-1) trials are uniquely capable of es...
Precision medicine typically refers to the use of genomic signatures of patients to assign more effe...
This is the final version of the article. Available from BioMed Central via the DOI in this record.B...
Clinicians and patients often try a treatment for an initial period to inform longer-term therapeuti...
Background: N-of-1 trials offer an innovative approach to delivering personalized clinical care toge...
AbstractN-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a ...
BACKGROUND: Many people now take multiple medications on a long-term basis to manage health conditio...
Treatment of patients who suffer from concurrent health conditions is not well served by (1) evidenc...
Objective: To explore the economic viability of N-of-1 trials for improving access to selected high ...
The aim of this article is to provide readers who have not yet undertaken n-of-1 or within-subject e...
BackgroundMany people now take multiple medications on a long-term basis to manage health conditions...
Although cannabis-based products for medicinal use are now legal in the UK, it is still challenging ...
AbstractObjectivesTo explore the economic viability of N-of-1 trials for improving access to selecte...
BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study c...
DOI
Add to ORKG